2013
DOI: 10.1016/j.biomaterials.2013.02.033
|View full text |Cite
|
Sign up to set email alerts
|

Osteogenicity of titanium implants coated with calcium phosphate or collagen type-I in osteoporotic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
67
2

Year Published

2014
2014
2019
2019

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 95 publications
(71 citation statements)
references
References 61 publications
2
67
2
Order By: Relevance
“…We used a dorsal approach similar to the procedure described by Alghamdi et al [43]. Buprenorphine (Temgesic ® , Reckitt Benckiser AG, Wallisellen, Switzerland) was administered subcutaneously before surgery and every 8 h for the first 48 h after surgery for pain relief.…”
Section: Ovariectomymentioning
confidence: 99%
“…We used a dorsal approach similar to the procedure described by Alghamdi et al [43]. Buprenorphine (Temgesic ® , Reckitt Benckiser AG, Wallisellen, Switzerland) was administered subcutaneously before surgery and every 8 h for the first 48 h after surgery for pain relief.…”
Section: Ovariectomymentioning
confidence: 99%
“…The second form of collagen scaffold is the nanofiber sheets 18,19 . The third form of collagen scaffold is the nanocomposites with inorganic phases like calcium phosphate mineral [20][21][22][23] . The main disadvantage of collagen as a material is the poor mechanical properties, which limit its applications.…”
Section: Introductionmentioning
confidence: 99%
“…biphosphonates) or anabolic agents (i.e. parathyroid hormone or bone morphogenetic protein) immobilised on the material surface in the osteoporotic condition, but, to the best of the authors' knowledge, few published papers have evaluated material surface functionalisation with collagen type I in an osteoporotic animal model [21,22].…”
Section: Discussionmentioning
confidence: 98%
“…For example, Stadlinger et al [22] found no detectable impact on the osteointegration parameter (BIC, BI and BV/TV and pull-out test) exerted by a collagen/chondroitin sulphate titanium coating at either two or four weeks after implant. In another in vivo study, Alghamdi et al [21] compared a CaP and collagen type I coated Ti implant to an uncoated one both in healthy and osteoporotic conditions, by adopting a similar experimental set up. Twelve weeks after implantation, the BV parameter measured with microtomography revealed no differences between coated and uncoated materials in either the SHAM or the OVX group.…”
Section: Discussionmentioning
confidence: 98%